How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Thinking about what to do with Recursion Pharmaceuticals stock right now? You are not alone. In just the past week, the stock has jumped an impressive 19.2%, adding to an 18.5% surge over 30 days. It ...

Oracle has linked an ongoing extortion campaign claimed by the Clop ransomware gang to E-Business Suite (EBS) vulnerabilities that were patched in July 2025. While the company has yet to attribute the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Oracle has fixed a zero-day vulnerability in one of its flagship business software products that a hacking group is currently abusing to steal personal information about corporate executives. In a ...

Following reports that the cybercriminal group Clop has been extorting E-Business Suite customers, Oracle linked the campaign to vulnerabilities addressed in July. The data extortion campaign ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Oracle released new renderings of its planned 70-acre campus set to transform Nashville's East Bank on Oct. 8. National interest in the development is growing as the company — poised to take over U.S.